Your browser doesn't support javascript.
loading
Traditional Tibetan medicine: therapeutic potential in lung diseases.
Li, Canlin; Li, Yuan; Huang, Xi; Li, Si; Sangji, Kangzhuo; Gu, Rui.
Afiliación
  • Li C; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Li Y; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Huang X; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Li S; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Sangji K; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Gu R; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Front Pharmacol ; 15: 1365911, 2024.
Article en En | MEDLINE | ID: mdl-38567353
ABSTRACT
Lung diseases have become a major threat to human health worldwide. Despite advances in treatment and intervention in recent years, effective drugs are still lacking for many lung diseases. As a traditional natural medicine, Tibetan medicine has had a long history of medicinal use in ethnic minority areas, and from ancient times to the present, it has a good effect on the treatment of lung diseases and has attracted more and more attention. In this review, a total of 586 Tibetan medicines were compiled through literature research of 25 classical works on Tibetan medicine, drug standards, and some Chinese and English databases. Among them, 33 Tibetan medicines have been studied to show their effectiveness in treating lung diseases. To investigate the uses of these Tibetan medicines in greater depth, we have reviewed the ethnomedicinal, phytochemical and pharmacological properties of the four commonly used Tibetan medicines for lung diseases (rhodiola, gentian, sea buckthorn, liexiang dujuan) and the five most frequently used Tibetan medicines (safflower, licorice, sandalwood, costus, myrobalan). It is expected to provide some reference for the development of new drugs of lung diseases in the future.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: China